Uganda secures 3,000 Ebola vaccine trial doses: The study is being conducted through a partnership involving the Uganda Virus Research Institute ...
monitor.co.ug/uganda/news/national/uganda-secures-3-000-ebola-vaccine-trial-doses-5629888
Uganda secures 3,000 Ebola vaccine trial doses
India’s HPV vaccine Cervavac gets WHO’s safety nod: Previously approved for its use in India by the drug controller, Cervavac is administered for the prevention ...
indianexpress.com/article/health-wellness/indias-hpv-vaccine-cervavac-who-safety-nod-10907396/
India’s HPV vaccine Cervavac gets WHO’s safety nod
Serum Institute emerges as early backer of Yotta: Adar Poonawalla's Serum Institute of India has invested ₹250 crore in Yotta Data Services.
livemint.com/companies/news/yotta-data-services-fundraise-serum-institute-250-crore-11789875417541.html
Serum Institute emerges as early backer of Yotta
OpinionRaja Ravi Varma and RK Laxman enter into an unlikely artistic dialogue at Pune exhibition
indianexpress.com/article/cities/pune/raja-ravi-varma-rk-laxman-exhibition-pune-museum-10840578/
Raja Ravi Varma and RK Laxman enter into an unlikely artistic dialogue at ...
Serum stockpiles Ebola vaccine candidate; supplies does for Phase 1 trial: The Serum Institute of India rapidly produced 620,000 doses of the ChAdOx1 Bundibugyo ...
financialexpress.com/business/industry-serum-stockpiles-ebola-vaccine-candidate-supplies-does-for-phase-1-trial-4290588/
Serum stockpiles Ebola vaccine candidate; supplies does for Phase 1 trial
In an effort to evaluate potential treatments for the Ebola disease caused by the Bundibugyo virus (BVD), the University of Oxford, England ... Show more

Oxford University & India's Serum Institute launch trials for Bundibugyo-borne Ebola disease
The first Phase 1 clinical trial begins for the vaccine candidate ChAdOx1 BDBV against the currently rampant Ebola virus species Bundibugyo ... Show more

Ebola Bundibugyo: First clinical vaccine trial begins - | German Medical Journal
Every year, thousands of workers in India’s automotive supply chain suffer crush injuries – most caused by severe compression on parts of the body ... Show more

The Wire: The Wire News India, Latest News,News from India, Politics, External Affairs, Science, Economics, Gender and Culture
Auto supply chain injuries rise 20%: Report : Power press accidents drive severe injuries
financialexpress.com/business/news/auto-supply-chain-injuries-rise-20-reportnbsp/4267233/
Auto supply chain injuries rise 20%: Report 
Scientists at the University of Oxford have said they are ‘working urgently’ to develop a new vaccine to help tackle the Ebola outbreak in the Democratic ... Show more
Key FactsWHO Elevates Ebola Threat Level in Congo to Very High
May 22, 2026 · Reading time: ~45 sec.
Summary created with AI assistance · Source: reuters.com
  • The WHO has raised the national risk level of the Bundibugyo Ebola strain in the Democratic Republic of Congo to very high.

  • There are currently 82 confirmed cases and seven confirmed deaths, alongside 177 suspected fatalities and nearly 750 suspected infections.

  • An experimental antiviral drug, Obeldesivir, may be administered to Ebola contacts to help prevent disease onset under strict protocols.

  • Preventative actions in Uganda, including intense contact tracing and event cancellations, have helped limit virus spread.
  • "We are now revising our risk assessment to very high at the national level, high at the regional level, and low at global level," WHO Chief Tedros Adhanom Ghebreyesus told reporters.— Tedros Adhanom Ghebreyesus, WHO Director-General, told reporters that the risk assessment was being revised.
How a Pune horse breeder built a $20 bn global vaccine empire: When FinancialExpress.com asked about his biggest achievement, “ That we never compromised on ...
financialexpress.com/business/news/how-a-pune-horse-breeder-built-a-20-bn-global-vaccine-empire/4249554/
How a Pune horse breeder built a $20 bn global vaccine empire
Serum Institute's Cyrus Poonawalla Buys Raja Ravi Varma Painting For Record Rs 167 Crore
ndtv.com/lifestyle/serum-institutes-cyrus-poonawalla-buys-raja-ravi-varma-painting-for-record-rs-167-crore-11301767
Serum Institute's Cyrus Poonawalla Buys Raja Ravi Varma Painting For ...
Octogenarian Indian tycoons in the pharma and consumer industries are believed to have been not only the buyer but also the seller of an oil on canvas (below) ... Show more

The Wire: The Wire News India, Latest News,News from India, Politics, External Affairs, Science, Economics, Gender and Culture
6.16 lakh. That is the estimated number of Indian women that would have lost their lives to cervical cancer between 2018 – when the path was cleared for the ... Show more

The Wire: The Wire News India, Latest News,News from India, Politics, External Affairs, Science, Economics, Gender and Culture
Serum Institute awaits clarity on customs duty on SEZ sales to domestic market : According to the announcement, SEZs will be allowed to sell in the DTA based on ...
financialexpress.com/business/industry-serum-institute-awaits-clarity-on-customs-duty-on-sez-sales-to-domestic-marketnbsp-4128879/
Serum Institute awaits clarity on customs duty on SEZ sales to domestic ...
From Deccan Chargers to RCB, the twists and turns in IPL team ownership: As Serum Institute of India CEO Adar Poonawala makes public his interest in buying RCB ...
forbesindia.com/photogallery/life/from-deccan-chargers-to-rcb-the-twists-and-turns-in-ipl-team-ownership/2990644/1
From Deccan Chargers to RCB, the twists and turns in IPL team ownership
Serum Institute of India CEO Adar Poonawalla set to make ‘strong and competitive’ bid for Royal Challengers Bengaluru
indianexpress.com/article/sports/cricket/adar-poonawalla-strong-bid-royal-challengers-bengaluru-rcb-10489309/
Serum Institute of India CEO Adar Poonawalla set to make ‘strong and ...
Adar Poonawalla enters race to buy RCB: Who else is in the queue?: Poonawalla joins a small but powerful list of potential acquirers of one of the most-followed ...
financialexpress.com/sports/adar-poonawalla-enters-race-to-buy-rcb-who-else-is-in-the-queue/4116319/
Adar Poonawalla enters race to buy RCB: Who else is in the queue?
HPV vaccination: Pune Zilla Parishad partners with Serum Institute of India, Jivika Foundation for roll out in Jan 2026
indianexpress.com/article/cities/pune/hpv-vaccination-pune-zilla-parishad-serum-institute-jivika-jan-2026-10416829/
HPV vaccination: Pune Zilla Parishad partners with Serum Institute of ...
Global vaccine alliance Gavi and its partner UNICEF will pay 25 percent less for a new malaria vaccine made by the Serum Institute of India within roughly a ... Show more
RCB is a great team, at the right valuation: Adar Poonawalla: Serum Institute CEO Adar Poonawalla has publicly expressed interest in acquiring the Indian Premier ...
financialexpress.com/sports/rcb-is-a-great-team-at-the-right-valuationnbspadar-poonawalla/3996068/
RCB is a great team, at the right valuation: Adar Poonawalla
Low vaccine stocks in focus as new covid variants spread: India has reported 1,010 active covid cases till 26 May, with seven people succumbing to the infection ...
livemint.com/news/india/covid-cases-surge-covid-19-committee-low-vaccine-stocks-surveillance-testing-new-variants-nb-1-8-1-and-lf7-11748511290760.html
Low vaccine stocks in focus as new covid variants spread
Karan Johar sells 50% stake in Dharma Productions for Rs 1,000 Crore—Meet his new billionaire business partner who has a net worth of Rs 1,07,533 Crore
gqindia.com/content/karan-johar-sells-50-stake-in-dharma-productions-for-rs-1000-crore-meet-his-new-billionaire-business-partner-who-has-a-net-worth-of-rs-107533-crore
Karan Johar sells 50% stake in Dharma Productions for Rs 1 ...
Key FactsNew Era for Bollywood Industry Through Poonawalla Deal
Oct 21, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: forbesindia.com
  • Adar Poonawalla's Serene Productions acquired a 50% stake in Dharma Productions for Rs1,000 crore.

  • This partnership may harm competitors like Saregama and Zee but signals a new era of corporatization in the industry.

  • Analysts believe Poonawalla's investment could lead to sustainable funding and a stronger production pipeline.

  • The collaboration merges Dharma's storytelling legacy with Poonawalla's strategic expertise and resources.
Key FactsThailand Reports First Mpox Case in Asia
Aug 23, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: itv.com
  • Thailand has confirmed its first case of a new, more dangerous strain of Mpox, marking the second confirmed case outside Africa. The patient, who traveled from an unnamed African country, was found to carry the clade 1b strain, as reported by the Thai Department of Disease Control.

  • Travelers arriving from 42 'risk countries' are required to register and undergo testing upon arrival in Thailand. If any symptoms resembling chickenpox are observed, further testing is mandated. The head of the Thai Department of Disease Control noted that Mpox is less likely to spread rapidly compared to Covid due to the close contact necessary for transmission.

  • Mpox, previously known as monkeypox, is a highly infectious disease primarily found in West and Central Africa. The new clade 1b strain has raised global concerns due to its increased infectivity and lethality. A case of this variant was confirmed in Sweden last week, indicating a potential spread beyond the African continent.

  • The World Health Organization (WHO) has declared a global health emergency in response to the new strain. According to the WHO, the spread of this deadlier variant can be managed and should not be compared to Covid. Over the past week, around 1,400 Mpox infections have been reported in Africa, raising the total to nearly 19,000 cases this year.
#FPNews : The work on manufacturing mpox vaccine has already started in India by the Pune-based Serum Institute of India, or SII ... Show more
The Ambani family tops the list of India's three richest families, whose total net worth is Rs 38 lakh Crore — equivalent to Singapore's GDP ...
gqindia.com/content/the-ambani-family-tops-the-list-of-indias-three-richest-families-whose-total-net-worth-is-rs-38-lakh-crore-equivalent-to-singapores-gdp-know-details-about-the-other-two
The Ambani family tops the list of India's three richest families ...
The Ambani family business, Reliance Industries, is valued at Rs 25.75 lakh crore.
Key FactsRich Indian Family Businesses
Aug 8, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: business-standard.com
  • India's most valuable family businesses collectively worth Rs 6,009,100 Crore, led by Ambani, Bajaj, and Birla.

  • Ambani family leads with Rs 2,575,100 Crore, followed by Bajaj and Birla. Other prominent families are also featured on the list.

  • Jindal family, Nadar family, and Mahindra family are also among the top rankings, with increasing presence of women in leadership roles.

  • Total valuation of top family businesses exceeding $1.3 trillion surpasses the combined GDPs of Switzerland and UAE, showcasing diversity and resilience across different sectors.
How is new malaria vaccine drive working in West Africa?: How does the new R21/Matrix-M vaccine work and where is it being administered?
aljazeera.com/news/2024/7/20/how-is-new-malaria-vaccine-drive-working-in-west-africa
How is new malaria vaccine drive working in West Africa?
World’s Largest Vaccine Maker Sees Demand Doubling in Five Years: Serum Institute of India Pvt. is expanding its production capacity as it expects sales of ...
trib.al/Jp76AAN
World’s Largest Vaccine Maker Sees Demand Doubling in Five Years
TIME's 'World's Most Influential Companies' list includes Reliance and Tata: Reliance Industries Limited has made its second appearance on the prestigious TIME ...
hindustantimes.com/business/times-worlds-most-influential-companies-list-includes-reliance-and-tata-101717079564074.html
TIME's 'World's Most Influential Companies' list includes Reliance and ...
Key FactsAstraZeneca ends global use of their Covid-19 vaccine
May 8, 2024 · Reading time: ~20 sec.
Summary created with AI assistance · Source: dailyecho.co.uk
  • On Tuesday, May 7, AstraZeneca announced the termination of the global use of their COVID-19 vaccine. This decision was primarily due to an abundance of available updated vaccines since the onset of the pandemic. The company's request to withdraw the vaccine was submitted on March 5 and became effective on May 7.

  • While the vaccine was determined to be safe and effective overall, there was a risk of a rare but severe side effect known as thrombosis with thrombocytopenia or TTS. This rare syndrome occurred in approximately two to three individuals per 100,000 vaccinated with the Vaxzevria vaccine.

  • The company had previously admitted in court documents that the vaccine could lead to side effects such as blood clots and low blood platelet counts. Several countries have already halted the distribution of the vaccine, and it has been unavailable in Australia since March 2023.
“An extraordinary force for good” US envoy as SII ships Malaria vaccines to Central African Republic#MalariaVaccine #CEO #SII #R21MatrixM #AfricanCountries #MalariaEndemic ss
Covaxin has ‘excellent track record’, says Bharat Biotech after study details side effects
scroll.in/latest/1067996/covaxin-has-excellent-track-record-says-bharat-biotech-after-study-details-side-effects
Covaxin has ‘excellent track record’, says Bharat Biotech after study ...
Covishield side effects: Doctors' group urges govt to review all Covid vaccines: New Delhi, May 9 (PTI) In the wake of pharmaceutical giant AstraZeneca admitting ...
deccanherald.com/india/covishield-side-effects-doctors-group-urges-govt-to-review-all-covid-vaccines-3015995
Covishield side effects: Doctors' group urges govt to review all Covid ...
PM Modi's photo removed from vaccine certificates amidst Covishield controversy: New Delhi: Amidst the ongoing controversy surrounding the Covishield vaccine ...
deccanchronicle.com/nation/pm-modis-photo-removed-from-vaccine-certificates-amidst-covishield-controversy-892042
PM Modi's photo removed from vaccine certificates amidst Covishield ...
AstraZeneca Confirms Rare Blood Clot Side Effect Associated with COVID-19 Vaccine
egyptianstreets.com/2024/05/02/astrazeneca-confirms-rare-blood-clot-side-effect-associated-with-covid-19-vaccine/
AstraZeneca Confirms Rare Blood Clot Side Effect Associated with COVID-19 ...
Key FactsAstrazeneca admits Covishield vaccine can cause rare side effect: Details revealed
Apr 30, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: indianexpress.com
  • AstraZeneca confirms a rare risk of blood clots (TTS) with the Covishield vaccine. An expert explains the symptoms of TTS, its causes, and who might be at risk. The doctor emphasizes that the benefits outweigh the risks and urges monitoring for early detection and treatment.

  • According to a report by The Telegraph, AstraZeneca has admitted for the first time in court documents that the Covishield vaccine may lead to a rare side effect. This could result in a significant reversal that may lead to a legal compensation in millions. The company is facing a class action lawsuit over allegations that its vaccine can cause a health issue known as Thrombosis with Thrombocytopenia Syndrome (TTS).

  • Dr. Jagadish J. Hiremath, a public health expert, explains that TTS is a rare condition characterized by the formation of blood clots in blood vessels and a low number of platelets. The exact mechanism of TTS post-Covishield vaccination is not fully understood, but it is speculated that the vaccine could trigger an immune response leading to platelet activation and clot formation.

  • TTS is an extremely rare condition where certain factors could make individuals more susceptible, such as age, gender (more common in younger women), and possibly genetic factors. Healthcare providers are encouraged to monitor TTS symptoms, especially in high-risk individuals, for prompt management and treatment.
AstraZeneca, Serum Institute to be sued by parents of woman who died after Covishield jab: What happened?
firstpost.com/explainers/astrazeneca-serum-institute-parents-woman-death-covishield-vaccine-side-effects-13766668.html
AstraZeneca, Serum Institute to be sued by parents of woman who died after ...
Meet the next generation of billionaires –Ananya Birla to Adar Poonawalla: Embark on a journey of wealth and influence as we introduce the rising stars of the ...
financialexpress.com/lifestyle/redefining-wealth-meet-the-next-generation-billionaire-prodigies-from-ananya-birla-to-adar-poonawalla/3429235/
Meet the next generation of billionaires –Ananya Birla to Adar Poonawalla
Homegrown Solution to India’s Cervical Cancer Dilemma: The cost and subsequent shortage of HPV vaccines has put preventing cervical cancer out of reach of many ...
thewire.in/health/homegrown-solution-to-indias-cervical-cancer-dilemma
Homegrown Solution to India’s Cervical Cancer Dilemma
NCP’s largest single-day encashment of electoral bonds came while in power: Election Commission reveals NCP received Rs 37.5 crore via electoral bonds ...
thehindu.com/data/ncp-received-its-largest-single-day-donation-of-electoral-bonds-while-in-power/article67962173.ece
NCP’s largest single-day encashment of electoral bonds came while in power
Key FactsPoll Bonds: India's Electoral Democracy Challenges - SC's Next Move
Mar 19, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: thewire.in
  • Fresh data on electoral bonds purchase patterns have emerged, with the Election Commission of India (ECI) publishing details of bonds sold and encashed before April 12, 2019.

  • The Bharatiya Janata Party (BJP) received Rs 2,658.35 crore in electoral bonds between March 2018 and April 2019, while the Congress party received Rs 530.1 crore.

  • The Supreme Court has a significant role in investigating the electoral bonds data scandal and ensuring transparency in political funding.

  • The courts could decide to disqualify the BJP from the upcoming elections if they find that the party is being supported through a corrupt financing scheme.
India's Serum looks beyond COVID with new vaccines for malaria, dengue: The CEO of the world's biggest vaccine maker, Serum Institute of India ...
reuters.com/business/healthcare-pharmaceuticals/indias-serum-looks-beyond-covid-with-new-vaccines-malaria-dengue-2024-03-10/
India's Serum looks beyond COVID with new vaccines for malaria, dengue
Photos: Celebrities and tycoons arrived on charter jets for a three-day-pre-wedding jamboree as Indian billionaire Mukesh Ambani kickstarts wedding ... Show more

Most extravagant wedding ever? Rihanna, Bill Gates, Ivanka Trump and Mark Zuckerberg among star-studded guests at Indian wedding - March 4, 2024 | Reuters
Key FactsAmbani Wedding: Lavish Celebration Raises Eyebrows
Mar 6, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: theguardian.com
  • The Ambani pre-wedding was a celebration of extravagance and luxury.

  • Reportedly costing $120 million, the event included extravagant details.

  • The celebration marks a return to conspicuous consumption, breaking away from the trend of discreet wealth.

  • Despite growing inequality and warnings of consequences, the super-rich show no restraint.
What Anant Ambani said about siblings Akash and Isha Ambani ahead of his wedding: Anant Ambani, Radhika Merchant's pre-wedding event: Ahead of his wedding with ...
hindustantimes.com/india-news/like-ram-and-mother-anant-ambani-on-bond-with-siblings-akash-and-isha-ambani-101709184671674.html
What Anant Ambani said about siblings Akash and Isha Ambani ahead of his ...
Meet billionaire Adar Poonawalla’s wife Natasha Poonawalla, who is the executive director of a Rs 1.92 lakh crore company
gqindia.com/content/meet-billionaire-adar-poonawallas-wife-natasha-poonawalla-who-is-the-executive-director-of-a-rs-192-lakh-crore-company
Meet billionaire Adar Poonawalla’s wife Natasha Poonawalla ...
COVID-19: Pharma company AstraZeneca sued in UK for deaths due to vaccine-induced blood clots, says report
wionews.com/world/global-study-reveals-2-very-rare-covid-19-vaccine-side-effects-previously-unknown-692993
COVID-19: Pharma company AstraZeneca sued in UK for deaths due to ...
Poonam Pandey ‘dies of cervical cancer’: What is Centre's vaccination plan?: Actor and model Poonam Pandey dies at 32 due to cervical cancer on Friday ...
hindustantimes.com/india-news/poonam-pandey-dies-of-cervical-cancer-what-is-centres-vaccination-plan-announced-in-interim-budget-2024-101706859838355.html
Poonam Pandey ‘dies of cervical cancer’: What is Centre's vaccination ...
Poonam Pandey ‘dies of cervical cancer’: What is Centre's vaccination plan?: Actor and model Poonam Pandey dies at 32 due to cervical cancer on Friday ...
hindustantimes.com/india-news/poonam-pandey-dies-of-cervical-cancer-what-is-centres-vaccination-plan-announced-in-interim-budget-2024-101706859838355.html
Poonam Pandey ‘dies of cervical cancer’: What is Centre's vaccination ...
Key FactsAICWA Demands FIR Against Poonam Pandey
Feb 3, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: hindustantimes.com
  • AICWA demands FIR against Poonam Pandey for false death publicity stunt.

  • Poonam Pandey used alleged cancer diagnosis for self-promotion.

  • AICWA requests Mumbai Police to file FIR against Poonam Pandey and her manager.

  • Poonam apologizes for PR stunt, claims intention was to raise awareness about the disease.
Can malaria vaccine rollout be scaled up? | Explained: As Cameroon becomes the first country in the world to launch the RTS, S malaria vaccine for children into ...
thehindu.com/sci-tech/health/can-malaria-vaccine-rollout-be-scaled-up-explained/article67784053.ece
Can malaria vaccine rollout be scaled up? | Explained
Farooq Abdullah furious over Ram temple event invitation. Here's why: Farooq Abdullah said that anybody who wants to visit the Ram temple could do so without any ...
hindustantimes.com/india-news/farooq-abdullah-furious-over-ram-temple-pran-pratishtha-ceremony-invitation-heres-why-101705662858442.html
Farooq Abdullah furious over Ram temple event invitation. Here's why
Clarifying the current protocols for JN.1 Covid-19 infections : Covid-19 is back in news with the WHO classifying JN.1 variant as "variant of interest" ...
thehindu.com/sci-tech/health/clarifying-the-current-protocols-for-jn1-covid-19-infections/article67680496.ece
Clarifying the current protocols for JN.1 Covid-19 infections
Key FactsNew Covid Strain JN.1 Dominates US Cases
Dec 28, 2023 · Reading time: ~20 sec.
Summary created with AI assistance · Source: nytimes.com
  • The JN.1 strain accounts for almost half of Covid cases in the US and is rapidly spreading.

  • It's unclear whether the increase in Covid cases is driven by the JN.1 strain or other factors like holiday travel.

  • Experts continue to recommend protective measures such as wearing masks, improved indoor ventilation, and the latest Covid vaccine as preliminary research shows the updated vaccines are effective against JN.1.